Source: International Congress 2017 – Novel and old entities
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Demirdogen Cetinoglu (Bursa, Turkey). Noninvasive Arterial Stiffness Measurement in Patients with Sarcoidosis. 3845

Member's Comments

No comment yet.

Related content which might interest you: CT Based Arterial and Venous Morphologic Changes In Pulmonary Hypertension Associated with COPD Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 Echocardiographic changes and Arterial Stiffness Index in patients with COPD Source: International Congress 2019 – Airway physiology Year: 2019 A Minimal Clinically Important Difference for CAMPHOR in Idiopathic Pulmonary Arterial Hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Contribution of BMP9 to Pulmonary Arterial Hypertension Source: International Congress 2017 – New perspectives from experimental models of pulmonary hypertension Year: 2017 Predictors of Progression in Patients with Pulmonary Sarcoidosis Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020 Multi-Omics Analysis of the PDGF Response in Pulmonary Vascular Smooth Muscle Cells from Patients with Pulmonary Arterial Hypertension: Implication of the NMDAR Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020 Comparison of Impulse Oscillometry With Spirometry in Patients With Non Cystic Fibrosis Bronchiectasis Source: Virtual Congress 2020 – Respiratory physiology and sleep: new approaches to diagnosis and treatment Year: 2020 Quantitative Assessment of Thoracic Muscles in Patients with Idiopathic pulmonary fibrosis :Relationship with Prognosis Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018 Differential Expression of Plasma Metabolites in Patients with Pulmonary Sarcoidosis is Associated with Clinical Behavior Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 Role of CHK1 in Pulmonary Arterial Hypertension Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Microvascular Endothelial Function in treated Pulmonary Arterial Hypertension Source: International Congress 2017 – Imaging and lung disease PH Year: 2017 Characterize Idiopathic Pulmonary Fibrosis using Respiratory Oscillometry Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Prognostic Factors in Patients with Idiopathic Pulmonary Fibrosis; Evaluation using Quantitative CT Analysis of Fibrosis and Emphysema Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Non-invasive cardiac output assessment in pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Nasal High-flow Versus Non-invasive Ventilation In Patients With Chronic Hypercapnic COPD Source: Virtual Congress 2020 – ALERT: Ventilation and rehabilitation Year: 2020 Exercise Pulmonary Vascular Resistances are Predictors of Survival in Systemic Sclerosis Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 The Effect of Delayed Onset Muscle Soreness on Pulmonary Function Parameters and ExerciseCapacity in Healthy Subjects Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease Year: 2021